China is a filing/registration market with a living technical annex (STSC) and, from 2026, a mandatory national safety standard sitting above it. Start with who you are (registrant/filer), then map special vs general cosmetics, then ingredients and claims.
China CSAR for SME cosmetic brands
China regulates cosmetics under CSAR: NMPA/provincial filing or registration, Safety and Technical Standards for Cosmetics (STSC), and from 2026 a mandatory national standard (GB 7916—2026) plus lighter filing paperwork under Announcement No. 70.
Who should care
Domestic registrants/filers and overseas brands using a China Responsible Person. Importers, infant/children SKUs, special cosmetics, and new-ingredient users should treat 2026 texts as a process reset — not optional reading.
Official sources
SME: first 5 things
-
1
Name the China legal person
Registrant/filer plus a domestic Responsible Person for imported products.
-
2
Split special vs general
Special cosmetics still register; general cosmetics file — duties differ.
-
3
Read No. 70 as process, not a free pass
Raw-material safety files move to on-site archive, but you still own the evidence.
-
4
Track STSC + GB 7916 together
NMPA describes a “one body, two wings” standard system. Implementation dates are not the publication date.
-
5
Treat NCI as its own project
New ingredients follow Announcement No. 59 from 15 July 2026; do not bury them in a finished-product file.
Obligation map
| Topic | SME note | Source |
|---|---|---|
| Registration / filing | NMPA platform duties | Official |
| New ingredients | No. 59 dossier rule from 15 Jul 2026 | Official |
| Safety standard | GB 7916 + STSC | Official |
| Testing methods | Methods incorporated into STSC by numbered announcements | Official |
| Claims & safety assessment | Shared dossiers allowed for similar formula systems under No. 70 | — |
Common pitfalls
- Confusing publication date with implementation date
- Deleting raw-material evidence because “NMPA no longer collects the code”
- Treating GB 7916 as a full replacement of STSC on day one
- Skipping infant/children extra controls
- Using animal-test relief without checking whether your product actually qualifies
More context
What this page covers
Mainland China CSAR orientation. Hong Kong, Macao, and Taiwan are different regimes. Always open the NMPA announcement, not a consulting recap.
Recent regulatory updates
All news- Guangdong Provincial Drug Administration Holds 2026 Cosmetics Quality and Safety Supervision Work Conference August 25, 2026
- Guangdong Issues Three-Year Action Plan to Promote Cosmetics Industry Transition from Scale Leadership to Quality Leadership August 25, 2026
- Guangdong Medical Products Administration Organizes Province-wide Inspection of Cosmetics Business Operations August 25, 2026
- Guangdong Medical Products Administration Convened a Symposium on the Special Report of the Research Project on the Management and Construction Planning of Cosmetic Efficacy Evaluation Standards August 25, 2026
- Interpretation of the Announcement of the National Medical Products Administration on Matters Concerning Cosmetic Registration and Filing August 25, 2026
- Notice of the Office of Guangdong Provincial Drug Administration on Issuing the Three-Year Action Plan for Improving the Production Quality Management System of Cosmetics Enterprises in Guangdong Province (2026-2028) August 25, 2026
- Announcement of the Guangdong Provincial Drug Administration on Publishing the List of the Second Batch of Cosmetics Electronic Label Pilot Enterprises in Guangdong Province August 25, 2026
- Announcement of the Guangdong Provincial Drug Administration on Cosmetics Supervision and Inspection (2026 Issue 1) August 25, 2026
Related Insights
Track updates in Workbench, or upgrade for full Regulatory Details and follow-up tools.
Always confirm requirements against official publications before decisions.